Ozempic
Ozempic Vision Loss Lawsuit Over Alleged NAION Risk From GLP-1 Drugs
A lawsuit alleges Novo Nordisk and Eli Lilly failed to warn of NAION vision loss from Ozempic and Mounjaro. The companies dispute it. Follow the case.
- Possible recovery
- Up to $50,000
Not a settlement payment. Depends on the case outcome.
- Claim deadline
- TBD
- Proof requirement
- TBD
Eligibility
Who may qualify?
Check the covered dates, products, locations, and other official terms before you file.
- You took a GLP-1 medication, and you were diagnosed with NAION or suffered sudden vision loss connected to that medication.
Case overview
What is the Ozempic case about?
A group of federal lawsuits has been consolidated into a single proceeding known as multidistrict litigation, or MDL. Patients bringing the cases allege that popular GLP-1 medications caused a rare and serious eye condition called non-arteritic anterior ischemic optic neuropathy, or NAION, sometimes referred to as an "eye stroke" because it can cause sudden and often permanent vision loss in one eye.
At the center of the litigation is the claim that drug makers failed to adequately warn patients and doctors of this risk. The companies deny wrongdoing and are fighting the allegations. No court has ruled on the claims, and whether these drugs actually cause NAION remains a matter of ongoing scientific debate.
Case details
- Company
- Novo Nordisk, Eli Lilly
Questions people ask
Frequently asked questions
How much could the Ozempic case pay?
The listed potential recovery is Up to $50,000. This is not a settlement payment. Any recovery depends on how the case is resolved.
Who qualifies for the Ozempic case?
Key eligibility criteria include: You took a GLP-1 medication, and you were diagnosed with NAION or suffered sudden vision loss connected to that medication. Always confirm the details with the sources on this page.
Is the Ozempic case a settlement?
No. This is a mass tort case that has not been resolved, and no court has approved a settlement, so there is no settlement fund or official claim form. Be cautious of any site asking you to file or pay for it today.
Is the Ozempic case open?
No claim process is open, because there is no settlement. TapClaim monitors the case for updates.
Sources
- Listing verificationLast checked Nov 2, 2026
